Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy.
NCT02930460 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2020-02-28
Summary
Prospective observational study of obstructive Sleep Apnea patients treated with Bilevel Positive Airway Pressure: AirCurve 10 VAutoTM
Conditions
Sponsors & Collaborators
-
ResMed
lead INDUSTRY
Principal Investigators
-
Alain Palot, MD · CHU Marseille
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2018-11-30
- Completion
- 2019-02-28
Countries
- France
Study Locations
More Related Trials
-
Efficacy of autoPPC for the Treatment of Obstructive Sleep Apnea Syndrome (OSAS)
NCT00875680 ·Status: UNKNOWN ·Phase: NA
-
Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)
NCT02522442 ·Status: COMPLETED ·Phase: NA
-
Adherence to Continuous Positive Airway Pressure Among Obstructive Sleep Apnoea Patients.
NCT02055027 ·Status: COMPLETED
-
CPAP Effect on Vascular Function in Obstructive Sleep Apnea
NCT02623088 ·Status: COMPLETED
-
Benefit of Cheyne-Stokes Respiration Remote Monitoring in CPAP-treated Patients With Obstructive Sleep Apnea to Detect Early Events of Heart Failure.
NCT03592108 ·Status: COMPLETED ·Phase: NA
-
Interest of Treatment of Obstructive Sleep Apnea Syndrome by Constant CPAP and Auto CPAP
NCT02749812 ·Status: COMPLETED ·Phase: NA
-
Continuous Positive Airway Pressure (CPAP) in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea (OSA)
NCT01335087 ·Status: COMPLETED ·Phase: NA
-
CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension
NCT02385864 ·Status: UNKNOWN
-
Variable Dead Space Rebreathing Device to Treat Sleep Apnea
NCT03552133 ·Status: COMPLETED ·Phase: NA
-
Trial of Auto Continuous Positive Airway Pressure (CPAP)
NCT01064258 ·Status: COMPLETED ·Phase: PHASE1
-
The Effectiveness of SensAwake™ for Continue Positive Airway Pressure Treatment of Obstructive Sleep Apnea Patients
NCT03294629 ·Status: COMPLETED ·Phase: NA
-
Compliance With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea Syndrome
NCT03776084 ·Status: UNKNOWN
-
Follow-up of Patients With Obstructive Sleep Apnea in Primary Care.
NCT01918449 ·Status: COMPLETED ·Phase: NA
-
A Post-marketing Surveillance of the Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea
NCT02698059 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Simple Continuous Positive Airway Pressure on Patients With Obstructive Sleep Apnea
NCT03782844 ·Status: COMPLETED ·Phase: NA
-
Structural and Functional Left Ventricular Remodelling in Patients With Obstructive Sleep Apnea
NCT00768807 ·Status: COMPLETED ·Phase: NA
-
Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease
NCT00738179 ·Status: UNKNOWN ·Phase: PHASE3
-
Positive Pressure Treatment of Obstructive Sleep Apnea
NCT00636181 ·Status: COMPLETED ·Phase: NA
-
Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASV
NCT02835638 ·Status: COMPLETED
-
Effects of Obstructive Sleep Apnea Treatment by Fixed CPAP and by Auto-CPAP (Somnosmart2)
NCT00633711 ·Status: COMPLETED ·Phase: PHASE4
-
Reiterative Development and Evaluation Study of OSA Therapy System
NCT01634074 ·Status: UNKNOWN
-
Cost-utility Study of Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnea Syndrome Patients
NCT01590420 ·Status: UNKNOWN ·Phase: PHASE4
-
Attentional Capacity and Working Memory in Coronary Artery Disease Patients: Impact of the Presence of a Sleep Apnea Syndrome and Chronic Effects of Treatment With CPAP
NCT02533050 ·Status: TERMINATED ·Phase: NA
-
Prevention of Airway Obstruction Events
NCT04873024 ·Status: COMPLETED ·Phase: NA
-
Effect of Continuous Positive Airway Pressure on Chronotype, Dietary Intake, and Cardiovascular Risk Markers
NCT04262960 ·Status: UNKNOWN ·Phase: NA